• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种采用[镓]镓-PSMA PET/CT的创新方法:PRIMARY评分与临床及组织病理学发现之间的关系。

An Innovative Approach with [Ga]Ga-PSMA PET/CT: The Relationship Between PRIMARY Scores and Clinical and Histopathological Findings.

作者信息

Mutevelizade Gozde, Bozdemir Bilal Cagri, Aydin Nazim, Sayit Elvan

机构信息

Department of Nuclear Medicine, School of Medicine, Manisa Celal Bayar University, 45030 Manisa, Turkey.

Department of Nuclear Medicine, Prof. Dr. Cemil Tascıoglu Hospital, University of Health Sciences, 34785 Istanbul, Turkey.

出版信息

Diagnostics (Basel). 2025 Jul 15;15(14):1779. doi: 10.3390/diagnostics15141779.

DOI:10.3390/diagnostics15141779
PMID:40722528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12294005/
Abstract

: The aim of this study was to investigate the relationship between the PRIMARY score derived from [Ga]Ga-PSMA PET/CT and key clinical and pathological parameters of prostate cancer aggressiveness, including the PSA level, ISUP Grade Group, and D'Amico risk classification, in patients with biopsy-proven prostate cancer. A secondary aim was to evaluate the interobserver agreement of the PRIMARY score in routine clinical practice. : This retrospective analysis included 51 patients with histopathologically confirmed prostate adenocarcinoma who underwent [Ga]Ga-PSMA PET/CT imaging for staging. PRIMARY scores were determined based on the intraprostatic uptake pattern, intensity, and zonal localization. These scores were compared with PSA levels, ISUP GG, D'Amico risk classification, and histopathological features such as the cribriform pattern, intraductal carcinoma, perineural invasion, extraprostatic extension, and lymphovascular invasion. The PRIMARY scores were independently assigned by a total of three nuclear medicine physicians, and interobserver agreement was calculated using Fleiss' kappa analysis. : Significant associations were found between the PRIMARY scores and the PSA level, ISUP Grade Group, and D'Amico risk classification. The most prevalent score was PRIMARY 5 (54.9%), which was significantly associated with ISUP GG 5 and the high-risk category in D'Amico classification. Among patients with PRIMARY Score 2, a substantial proportion (64.7%) had ISUP GG ≥ 3, and 58.8% were in the high-risk group, highlighting the limitations of binary PRIMARY classification. No statistically significant correlations were found between the PRIMARY scores and specific histopathologic features. Interobserver agreement was excellent (κ = 0.833). : The PRIMARY score demonstrates high reproducibility and clinical relevance in stratifying prostate cancer aggressiveness. However, the findings challenge the reliability of binary classifications, particularly for patients with Score 2, who may still harbor high-grade disease. Integrating imaging-based scores with clinical and histopathological data is essential, particularly for accurate staging and decision-making regarding active surveillance.

摘要

本研究的目的是调查经活检证实患有前列腺癌的患者中,[镓]Ga-PSMA PET/CT得出的PRIMARY评分与前列腺癌侵袭性的关键临床和病理参数之间的关系,这些参数包括前列腺特异抗原(PSA)水平、国际泌尿病理学会(ISUP)分级组以及达米科风险分类。次要目的是评估在常规临床实践中PRIMARY评分的观察者间一致性。:这项回顾性分析纳入了51例经组织病理学证实为前列腺腺癌且接受[镓]Ga-PSMA PET/CT成像进行分期的患者。PRIMARY评分是根据前列腺内摄取模式、强度和分区定位来确定的。将这些评分与PSA水平、ISUP GG、达米科风险分类以及组织病理学特征(如筛状模式、导管内癌、神经周围侵犯、前列腺外扩展和淋巴管侵犯)进行比较。PRIMARY评分由总共三名核医学医师独立赋值,并使用Fleiss' kappa分析计算观察者间一致性。:在PRIMARY评分与PSA水平、ISUP分级组和达米科风险分类之间发现了显著关联。最常见的评分是PRIMARY 5(54.9%),它与ISUP GG 5和达米科分类中的高危类别显著相关。在PRIMARY评分2的患者中,很大一部分(64.7%)的ISUP GG≥3,58.8%属于高危组,这突出了PRIMARY二元分类的局限性。在PRIMARY评分与特定组织病理学特征之间未发现统计学上的显著相关性。观察者间一致性极佳(κ = 0.833)。:PRIMARY评分在对前列腺癌侵袭性进行分层方面显示出高再现性和临床相关性。然而,研究结果对二元分类的可靠性提出了挑战,特别是对于评分2的患者,他们可能仍患有高级别疾病。将基于影像的评分与临床和组织病理学数据相结合至关重要,特别是对于准确分期和关于主动监测的决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/692e/12294005/0a6bbf881dc2/diagnostics-15-01779-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/692e/12294005/0a6bbf881dc2/diagnostics-15-01779-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/692e/12294005/0a6bbf881dc2/diagnostics-15-01779-g001.jpg

相似文献

1
An Innovative Approach with [Ga]Ga-PSMA PET/CT: The Relationship Between PRIMARY Scores and Clinical and Histopathological Findings.一种采用[镓]镓-PSMA PET/CT的创新方法:PRIMARY评分与临床及组织病理学发现之间的关系。
Diagnostics (Basel). 2025 Jul 15;15(14):1779. doi: 10.3390/diagnostics15141779.
2
Therapeutic Consequences of Ga-PSMA-11-PET/CT in Prostate Cancer in Correlation to the Gleason Score, PSA Value, and D'Amico-Defined Risk Groups.镓-PSMA-11-PET/CT在前列腺癌中的治疗效果与 Gleason 评分、PSA 值及达米科定义的风险组的相关性
Cancers (Basel). 2025 Jun 11;17(12):1944. doi: 10.3390/cancers17121944.
3
Machine learning-based construction and validation of an radiomics model for predicting ISUP grading in prostate cancer: a multicenter radiomics study based on [68Ga]Ga-PSMA PET/CT.基于机器学习构建和验证用于预测前列腺癌ISUP分级的放射组学模型:一项基于[68Ga]镓-PSMA PET/CT的多中心放射组学研究
Eur J Nucl Med Mol Imaging. 2025 Jun 24. doi: 10.1007/s00259-025-07412-x.
4
68 Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters.68Ga-PSMA-11 PET/CT 成像在脑胶质瘤中的应用及其与临床病理预后参数的相关性。
Clin Nucl Med. 2023 Dec 1;48(12):e559-e563. doi: 10.1097/RLU.0000000000004903. Epub 2023 Oct 23.
5
Diagnostic Performance of PSMA-Based 18 F-DCFPyL PET/CT in Prostate Cancer Patients After Definitive Treatment With PSA Level ≤0.2 ng/mL.基于 PSMA 的 18 F-DCFPyL PET/CT 在 PSA 水平≤0.2ng/mL 的前列腺癌患者确定性治疗后对前列腺癌的诊断性能。
Clin Nucl Med. 2023 Dec 1;48(12):1021-1027. doi: 10.1097/RLU.0000000000004893. Epub 2023 Oct 5.
6
Comparative evaluation of the performance of F-PSMA-1007 PET/CT and Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence.F-PSMA-1007 PET/CT与Ga-PSMA-11 PET/CT在生化复发前列腺癌患者中的性能比较评估
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2025 Jun 21:500178. doi: 10.1016/j.remnie.2025.500178.
7
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
8
Tumor Segmentation on PSMA PET/CT Predicts Survival in Biochemical Recurrence of Prostate Cancer: A Retrospective Study Using [Ga]Ga-PSMA-11 and [F]-PSMA-1007.基于PSMA PET/CT的肿瘤分割可预测前列腺癌生化复发后的生存率:一项使用[镓]镓-PSMA-11和[氟]氟-PSMA-1007的回顾性研究
Cancers (Basel). 2025 Jul 4;17(13):2249. doi: 10.3390/cancers17132249.
9
Optimizing treatment for Gleason 10 prostate cancer: radiation dose escalation and Ga-PSMA-PET/CT staging.优化 Gleason 10 前列腺癌的治疗:放射剂量递增与 Ga-PSMA-PET/CT 分期
Strahlenther Onkol. 2025 Feb 28. doi: 10.1007/s00066-025-02376-1.
10
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.

本文引用的文献

1
Which patients with negative PSMA-PET imaging can safely avoid biopsy for prostate cancer? a novel step towards PSMA-based biopsy-free strategy.哪些PSMA-PET成像阴性的患者可以安全地避免前列腺癌活检?迈向基于PSMA的无活检策略的新一步。
Eur J Nucl Med Mol Imaging. 2025 May;52(6):2051-2062. doi: 10.1007/s00259-025-07089-2. Epub 2025 Jan 25.
2
Current insights on PSMA PET/CT in intermediate-risk prostate cancer: a literature review.当前关于PSMA PET/CT在中危前列腺癌中的见解:一项文献综述。
Ann Nucl Med. 2025 Mar;39(3):247-254. doi: 10.1007/s12149-025-02015-w. Epub 2025 Jan 15.
3
Automatic Characterization of Prostate Suspect Lesions on T2-Weighted Image Acquisitions Using Texture Features and Machine-Learning Methods: A Pilot Study.
使用纹理特征和机器学习方法对T2加权图像采集中的前列腺可疑病变进行自动特征描述:一项初步研究。
Diagnostics (Basel). 2025 Jan 4;15(1):106. doi: 10.3390/diagnostics15010106.
4
The Role of Dynamic Contrast Enhanced Magnetic Resonance Imaging in Evaluating Prostate Adenocarcinoma: A Partially-Blinded Retrospective Study of a Prostatectomy Patient Cohort With Whole Gland Histopathology Correlation and Application of PI-RADS or TNM Staging.动态对比增强磁共振成像在评估前列腺腺癌中的作用:一项对前列腺切除患者队列进行的部分盲法回顾性研究,该研究将全腺体组织病理学相关性与PI-RADS或TNM分期的应用相结合。
Prostate. 2025 Apr;85(5):413-423. doi: 10.1002/pros.24843. Epub 2024 Dec 19.
5
PRIMARY scoring in 68Ga-PSMA PET/CT: correlation with prostate cancer risk groups and its potential impact on active surveillance.68Ga-PSMA PET/CT中的PRIMARY评分:与前列腺癌风险组的相关性及其对主动监测的潜在影响。
Ann Nucl Med. 2025 Apr;39(4):334-341. doi: 10.1007/s12149-024-02004-5. Epub 2024 Nov 23.
6
The impact of integrating PRIMARY score or SUVmax with MRI-based risk models for the detection of clinically significant prostate cancer.将PRIMARY评分或SUVmax与基于MRI的风险模型相结合用于检测临床显著性前列腺癌的影响。
Eur J Nucl Med Mol Imaging. 2025 Jan;52(2):756-765. doi: 10.1007/s00259-024-06916-2. Epub 2024 Sep 12.
7
NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024.NCCN 指南®洞察:前列腺癌,第 3.2024 版。
J Natl Compr Canc Netw. 2024 Apr;22(3):140-150. doi: 10.6004/jnccn.2024.0019.
8
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.EAU-EANM-ESTRO-ESUR-ISUP-SIOG 前列腺癌指南-2024 更新。第一部分:筛查、诊断和以治愈为目的的局部治疗。
Eur Urol. 2024 Aug;86(2):148-163. doi: 10.1016/j.eururo.2024.03.027. Epub 2024 Apr 13.
9
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
10
Prediction of clinically significant prostate cancer by [ Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance.[68Ga]Ga-PSMA-11 PET/CT 预测临床显著前列腺癌:主动监测患者选择的潜在工具。
Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1467-1475. doi: 10.1007/s00259-023-06556-y. Epub 2023 Dec 19.